recombinant asparaginase erwinia chrysanthemi-rywn (Rylaze)

From Aaushi
Jump to navigation Jump to search
[1]

Indications

* for patients allergic to asparaginase products derived from Escherichia coli

Notes

  • Jazz Pharmaceuticals

More general terms

References

  1. ↑ Bankhead C FDA OKs Key Component of Acute Leukemia Regimen Recombinant asparaginase fills need for patients allergic to standard products. MedPage Today July 1, 2021 https://www.medpagetoday.com/oncology/leukemia/93380
Retrieved from "https://aaushi.info/w/index.php?title=A57238&oldid=1068211"